{'fraction_non_alphanumeric': 0.024539877300613498, 'fraction_numerical': 0.00408997955010225, 'mean_word_length': 5.533333333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pre-clinical optical molecular imaging in the lung: technological challenges and future prospects.

In recent years, the fledgling field of small animal fluorescence molecular imaging has enabled great advances in pre-clinical research, driven by the development of both new optical imaging modalities at the macroscopic and microscopic scales (1), and novel classes of targeted imaging probes that report on the molecular status of cells and target tissues with exquisite specificity (2).